Get started
Author

Matthias Gerlach

N-Benzoylated Phenoxazines and Phenothiazines: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2011 · Helge Prinz, Behfar Chamasmani, et al. · Journal of Medicinal Chemistry · 65
Sulfonate Derivatives of Naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-Anthracenone as Highly Active Antimicrotubule Agents. Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2007 · Anne Zuse, Peter Schmidt, et al. · Journal of Medicinal Chemistry · 52
Metalated 2-Alkenylsulfoximines: Efficient Solutions for Asymmetric d3-Synthons
1996 · Michael Reggelin, Heinz Weinberger, et al. · Journal of the American Chemical Society · 36
Metallated 2-Alkenyl Sulfoximines in Asymmetric Synthesis: Regio- and Stereoselective Synthesis of Highly Substituted Oxabicyclic Ethers and Studies Towards the Total Syntheses of the Euglobals G1 and G2 and Arenaran A
1999 · Michael Reggelin, Matthias Gerlach, et al. · European Journal of Organic Chemistry · 35
10-(2-oxo-2-Phenylethylidene)-10H-anthracen-9-ones as Highly Active Antimicrotubule Agents: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2009 · Helge Prinz, Peter Schmidt, et al. · Journal of Medicinal Chemistry · 27
9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as Novel Antimicrotubule AgentsSynthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2006 · Anne Zuse, Peter Schmidt, et al. · Journal of Medicinal Chemistry · 26
Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety
2010 · Holger C. Nickel, Peter Schmidt, et al. · European Journal of Medicinal Chemistry · 23
A Convenient Synthesis of Novel 2,8-Disubstituted Pyrido[3,4-b]pyrazines Possessing Biological Activity
2011 · Pascal Marchand, Maud Antoine, et al. · Synthesis · 22
Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents—synthesis, antiproliferative activity and inhibition of tubulin polymerization
2011 · Helge Prinz, Peter Schmidt, et al. · Bioorganic & Medicinal Chemistry · 18
Translational potential of the ghrelin receptor agonist macimorelin for seizure suppression in pharmacoresistant epilepsy
2021 · An Buckinx, Anouk Pierre, et al. · European Journal of Neurology · 12
PDF
Discovery of 7‐Aryl‐Substituted (1,5‐Naphthyridin‐4‐yl)ureas as Aurora Kinase Inhibitors
2013 · Julien Defaux, Maud Antoine, et al. · ChemMedChem · 12
Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells
2014 · Julien Defaux, Maud Antoine, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Preparation of Novel 2,3,8-Trisubstituted Pyrido[3,4-b]pyrazines and Pyrido[2,3-b]pyrazines
2011 · Pascal Marchand, Maud Antoine, et al. · Synthesis · 7
Design and Synthesis of a Focused Library of Novel Aryl‐ and Heteroaryl‐Ketopiperazides
2004 · Matthias Gerlach, Eckhard Claus, et al. · Archiv der Pharmazie · 7
Efficient synthesis of novel disubstituted pyrido[3,4-b]pyrazines for the design of protein kinase inhibitors
2015 · Maud Antoine, Tilmann Schuster, et al. · MedChemComm · 5
Abstract 871: Dual inhibition of PI3K and Erk1/2 shows synergy and efficacy in human tumor cells, either by using drug combinations or novel dual PI3K/Erk inhibitors
2012 · Irene Seipelt, Matthias Gerlach, et al. · Cancer Research · 3
Abstract 5476: LHRH receptor targeting as mechanism of anti-tumor activity for cytotoxic conjugates of Disorazol Z with the LHRH receptor agonistic peptide D-Lys6-LHRH.
2013 · Babette Aicher, Tilmann Schuster, et al. · Cancer Research · 1
ChemInform Abstract: A Convenient Synthesis of Novel 2,8‐Disubstituted Pyrido[3,4‐b]pyrazines Possessing Biological Activity.
2012 · Maud Antoine, Matthias Gerlach, et al. · ChemInform · 1
ChemInform Abstract: Preparation of Novel 2,3,8‐Trisubstituted Pyrido[3,4‐b]pyrazines and Pyrido[2,3‐b]pyrazines.
2011 · Maud Antoine, Michael Czech, et al. · ChemInform · 1
Abstract 3563: A highly selective Erk1/2 Inhibitor with in-vivo anti tumor potency
2011 · Irene Seipelt, Eckhard Guenther, et al. · Cancer Research · 1
2-Hydroxy-4,6-dimethoxy-3-(3-methylbutanoyl)benzaldehyde
2007 · Jan W. Bats, Matthias Gerlach, et al. · Acta Crystallographica Section C Crystal Structure Communications · 1
4-Substituted-piperazin-1-yl-carbonyl-pyrazol derivatives: A new class of highly potent cytotoxic compounds with inhibitory effects on tubulin polymerization
2004 · Silke Baasner, Matthias Gerlach, et al. · Cancer Research · 1
Abstract 3711: Erk inhibition as a therapeutic option for the treatment of Raf- and Mek- inhibitor resistant tumors
2014 · Irene Seipelt, Peter Schmidt, et al. · Cancer Research
New Insights Into the Pathogenesis of Type 1 Diabetes
2013 · von Herrath, Gerlach Matthias · 2013 CIS Annual Meeting: Regulation & Dysregulation of Immunity April 25 - 28, 2013
Cytotoxic conjugates of Disorazol Z with the LHRH receptor agonistic peptide D-Lys(6)-LHRH as approach to targeted therapy of LHRH-R positive tumors
2013 · Gerlach, Matthias, Aicher, Babette, et al. · GRO
Works count: 30
Citation count: 365
H-index: 11
I10-index: 11
Year
Topic
Type